ChromaDex Corp. (CDXC)

[BlackBat]

Niagen, the main Chromadex product, does appear to have fantastic potential.

However, the lack of clinical trial data on humans, as opposed to mice, is probably stopping a lot of people jumping in and:

a) Buying shares in it
b) Actually using it - though at the price it is probably cheaper than a daily Mars Bar.

Reading the CEOs letter dated Feb. 23, 2017, he states that a clinical trial involving 140 people is underway, but gives no timescale as to when it will be concluded.

If the results from this trail are positive, and the current court case is successfully resolved, then I would think most people who are currently undecided would jump in, and the stock begin to move.

So, is there any indication as to when the latest clinical trail will be concluded?

Cheers,

BlackBat